LIPI Discover Anticancer Compound of Galangal - Galangal is known as one of the herbs turned out to have another added value that ginger oil, which can be used as an anticancer compound.
"Currently LIPI has developed an anticancer compound derived from oil-derived compound is methyl zinamat galangal. Own research has been done approximately 5 to 10 years," said Dr. Arthur Lelono, Disemenasi and Management Head of Research Results LIPI when contacted Liputan6.com Tekno team via telephone, Monday (10/12/2015).
Dr. Arthur also said that apart from oil galangal, LIPI also doing research for anticancer compound derived from cloves are compounds euganol.
"For the time being the most prepared are methyl zinamat and has also been produced. The result of their production of approximately 10 to 25 kg per month," said Dr. Arthur.
However, these compounds are not directly usable because it still needs to be mixed with other materials that will be the process of adjusting the needs of pharmaceutical companies that want to use it.
"Methyl zinamat now ready in clinical trials. However, for clinical trials LIPI in cooperation with several hospitals to conduct a trial," added Dr. Arthur.
He also revealed that the reciprocal of the discovery of this compound is later LIPI research will get royalties from companies using this compound.
In addition to several anticancer compounds, LIPI has also succeeded in developing compounds for cardiovascular and diabetes mellitus are derived from breadfruit leaf extract. In fact, these compounds are reportedly ready to undergo clinical trials and is expected to enter the industry next year.
No comments:
Post a Comment